About Us
About Isofol
Business Concept
Organisation
Management
Isofol team
Advisors
Collaborators
History
Research & Development
Clinical studies
About colorectal cancer
Medical need & Marketing potential
Treatment of colorectal cancer
About Osteosarcoma
Rescue therapy in osteosarcoma
Treatment of other types of cancer
Publications
Intellectual proporty rights
arfolitixorin
About arfolitixorin
Arfolitixorin animation
Scientific concept
Investor Relations
Share information
Analysts
Company Presentation
IPO
Financial Reports
Financial Calendar
IR Contact and Certified Adviser
Share owners
Corporate Governance
Corporate Governance
Corporate Governance Reports
Articles of Association
General Meetings
Remuneration Committee
Remuneration
Incentive Programs
Clinical and Regulatory committee
Auditors
Nomination Committee
Board
Management
News & Press
News & Press
Media coverage
Subscribe
Archive
Contact
Visit us
Career
Management
Isofol team
About Us
About Isofol
Business Concept
Organisation
Management
Isofol team
Advisors
Collaborators
History
Research & Development
Clinical studies
About colorectal cancer
Medical need & Marketing potential
Treatment of colorectal cancer
About Osteosarcoma
Rescue therapy in osteosarcoma
Treatment of other types of cancer
Publications
Intellectual proporty rights
arfolitixorin
About arfolitixorin
Arfolitixorin animation
Scientific concept
Investor Relations
Share information
Analysts
Company Presentation
IPO
Financial Reports
Financial Calendar
IR Contact and Certified Adviser
Share owners
Corporate Governance
Corporate Governance
Corporate Governance Reports
Articles of Association
General Meetings
Remuneration Committee
Remuneration
Incentive Programs
Clinical and Regulatory committee
Auditors
Nomination Committee
Board
Management
News & Press
News & Press
Media coverage
Subscribe
Archive
Contact
Visit us
Career
Management
Isofol team
Corporate Governance Reports
Corporate Governance
Reports
Document
:
Corporate Governance Report – Year of operation 2017 (Swedish)
